Skip to main content

Program Management

Schedules

TAFS: 075-0511 /X - Program Management

Iterations:
Adjustment authority: Yes
Reporting categories: No
Line #SplitDescriptionIteration 1
Previously Approved Amount
Iteration 2
OMB Action Amount
Footnotes
1000DEDiscretionary Estimated- Unob Bal: Brought forward, October 1$104,765,591 $104,765,591
1000MEMandatory Estimated - Unob Bal: Brought forward, October 1$5,166,712,091+$350,000
$5,167,062,091
1200BA: Mand: Appropriation$95,000,000 $95,000,000
1740BA: Disc: Spending auth:Antic colls, reimbs, other$30,800,000 $30,800,000
1801BA: Mand: Spending auth: Chng uncoll pymts Fed src$268,010,151 $268,010,151
1802BA: Mand: Spending auth: Previously unavailable$99,439,271 $99,439,271
1823BA: Mand: Spending auth: New\Unob bal temp reduced-$81,910,124 -$81,910,124
1840BA: Mand: Spending auth:Antic colls, reimbs, other$1,432,019,722 $1,432,019,722
1920Total budgetary resources avail (disc. and mand.)$7,114,836,702+$350,000
$7,115,186,702
6001Category A -- 1st quarter$77,783,221 $77,783,221
6002Category A -- 2nd quarter$64,838,058 $64,838,058
6003Category A -- 3rd quarter$64,570,293 $64,570,293
6004Category A -- 4th quarter$53,051,824 $53,051,824
6013Extending the Independence at Home Medical Practice Demonstration Program (Sec 105, P.L. 116-260)$4,000,000 $4,000,000
6019Provider Enrollment Fees (ACA 6401, P.L.111-148)$67,692,526 $67,692,526
6014Diagnostic Lab Tests (ACA 3113, P.L. 111-148)$0 Line removed
6022Nursing Home CMPs (ACA 6111, P.L.111-148)$13,101,662 $13,101,662
6016Community Prevention (ACA 4202, P.L. 111-148)$0 Line removed
6023RAC Retention Fees (MACRA 505, P.L.114-10)$26,984,823 $26,984,823
6017GNE Demonstration (ACA 5509, P.L.111-148)$0 Line removed
6024SHIPS (Consolidated Appropriations Act Sec. 103, P.L. 116-260)$14,145,000 $14,145,000
6018Medicare and Medicaid Extenders Act of 2010 (Section 206, P.L. 111-309)$0 Line removed
6026Clinical Diagnostic Laboratory Test (PAMA 216, P.L.113-93)$3,690,000 $3,690,000
6028Ensuring Accurate Valuation of Services (PAMA 220, P.L.113-93)$2,600,000 $2,600,000
6021Medicaid Regulations Study and Report (Section 7001, P.L. 110-252)$0 Line removed
6038Open Payments CMPs (ACA 6002, P.L.111-148)$3,460,816 $3,460,816
6042Medicare Ambulance Services (BBA 50203, P.L.115-123)$1,614,749 $1,614,749
6044Recovery Audit Contractors - Part A/B (Section 302, P.L.109-432)$134,355,000 $134,355,000
6046Recovery Audit Contractors - MSP (Section 302, P.L.109-432)$60,855,128 $60,855,128
6025Value-Based Purchasing Program for SNFs (PAMA 215, P.L.113-93)$0 Line removed
6048Marketplace User Fees (Section 1311&1321, P.L.111-148)$1,927,462,861 $1,927,462,861
6049Risk Adjustment User Fees (Section 1343, P.L.111-148)$69,644,006 $69,644,006
6050Extension of Funding for Quality Measure (Consolidated Appropriations Act Sec. 102, P.L. 116-260)$25,182,681 $25,182,681
6029Post-Acute Care Common Measurement Tool (IMPACT 2a, P.L.113-185)$0 Line removed
6051Expanding the Use of Telehealth Services (SUPPORT 2001, P.L.115-271)$12,135+$350,000
$362,135
6032Assessment and Analysis on Adjustments (IMPACT 2d2D, P.L.113-185)$0 Line removed
6053Grants to Provide Technical Assistance to Outlier Prescribers (SUPPORT 6052, P.L.115-271)$2,881,388 $2,881,388
6034Repealing SGR and Improving Medicare Payments (MACRA 101, P.L.114-10)$0 Line removed
6055Recovery Audit Contractors - Part D (Section 302, P.L. 109-432)$500,000 $500,000
6057Repeal Medicare Payment Cap Therapy Services (BBA 50202)$5,000,000 $5,000,000
6039Prohibition of Inclusion of SSNs (MACRA 501, P.L.114-10)$0 Line removed
6058Beneficiary Enrollment Simplification (Consolidated Appropriations Act Sec. 120, P.L. 116-260)$275,000 $275,000
6040Treatment of Cancer Hospitals (CURES 16002, P.L.114-255)$0 Line removed
6059Implementation Funding (Consolidated Appropriations Act Sec. 501, P.L. 116-260)$6,170,000 $6,170,000
6041Medicare Site-of-Service (CURES 4011, P.L.114-255)$0 Line removed
6062Medicare Payment for Rural Emergency Hospital Services (Consolidated Appropriations Act Sec. 125, P.$8,606,368 $8,606,368
6063Establishing Hospice Program Survey and Enforcement Procedures Under the Medicare Program (CAA 407)$9,445,000 $9,445,000
6064Independent Dispute Resolution User Fees (No Surprises Act Sec. 103, 105, 112, P.L. 116-260)$800,000 $800,000
6065Postal Service Reform Act of 2022 (H.R. 3076)$7,500,000 $7,500,000
6066Lowering Prices through Drug Price Negotiation Implementation (Inflation Reduction Act Sec. 11004, H$95,420,000 $95,420,000
6067Part B Price Inflation Rebate Implementation (Inflation Reduction Act Sec. 11101, H.R. 5376)$16,000,000 $16,000,000
6068Part D Price Inflation Rebate Implementation (Inflation Reduction Act Sec. 11102, H.R. 5376)$9,810,000 $9,810,000
6069Part D Redesign Implementation (Inflation Reduction Act Sec. 11201, H.R. 5376)$38,600,000 $38,600,000
6070Appropriate Cost-Sharing for Covered Insulin Products Under Medicare Part D (Inflation Reduction Act$1,000,000 $1,000,000
6071Part D Cost Sharing Implementation (Inflation Reduction Act Sec. 11202, H.R. 5376)$10,000,000 $10,000,000
6056Quality Incentives Computed Tomography (PAMA 218, P.L. 113-93)$0 Line removed
6072Health Services in School Settings / Technical Assistance Center (BSCA Section 11003, P.L. 117-159)$6,000,000 $6,000,000
6073NSA Plan and Issuer Enforcement CMPs Part A Collections (ACA Sec 104 & 106, P.L. 111-148)$589,375 $589,375
6074NSA Plan and Issuer Enforcement CMPs Part D Collections (ACA Sec 104 & 106, P.L. 111-148)$589,375 $589,375
6075Early and Periodic Screening, Diagnosis, and Treatment Benefit - Guidance and Reporting (BSCA Sec. 1$2,250,000 $2,250,000
6076Skilled Nursing Facility Value-Based Purchasing (CAA Sec. 111, P.L. 116-260)$3,260,000 $3,260,000
617015Apportioned in FY 2024 and future fiscal years - Assessment and Analysis on Adjustments (IMPACT 2d2D$575,173 $575,173
617030Apportioned in FY 2024 and future fiscal years - Beneficiary Enrollment Simplification (Consolidated$5,174,210 $5,174,210
61701Apportioned in FY 2024 and future fiscal years - Category A$252,835,797 $252,835,797
617012Apportioned in FY 2024 and future fiscal years - Clinical Diagnostic Laboratory Test (PAMA 216, P.L.$2,075,361 $2,075,361
61704Apportioned in FY 2024 and future fiscal years - Community Prevention (ACA 4202, P.L. 111-148)$37,987,007 $37,987,007
61703Apportioned in FY 2024 and future fiscal years - Diagnostic Lab Tests (ACA 3113, P.L. 111-148)$1,250,595 $1,250,595
617039Apportioned in FY 2024 and future fiscal years - Early and Periodic Screening, Diagnosis, and Treatm$2,465,000 $2,465,000
617013Apportioned in FY 2024 and future fiscal years - Ensuring Accurate Valuation of Services (PAMA 220,$1,822,221 $1,822,221
617032Apportioned in FY 2024 and future fiscal years - Establishing Hospice Program Survey and Enforcement$6,267,672 $6,267,672
61702Apportioned in FY 2024 and future fiscal years - Extending the Independence at Home Medical Practice$1,898,479 $1,898,479
617025Apportioned in FY 2024 and future fiscal years - Extension of Funding for Quality Measure (Consolida$3,578,351 $3,578,351
61705Apportioned in FY 2024 and future fiscal years - GNE Demonstration (ACA 5509, P.L.111-148)$14,033,780 $14,033,780
617026Apportioned in FY 2024 and future fiscal years - Grants to Provide Technical Assistance to Outlier P$63,692,345 $63,692,345
617038Apportioned in FY 2024 and future fiscal years - Health Services in School Settings / Technical Assi$2,000,000 $2,000,000
617031Apportioned in FY 2024 and future fiscal years - Implementation Funding (Consolidated Appropriations$16,299,998 $16,299,998
617033Apportioned in FY 2024 and future fiscal years - Lowering Prices through Drug Price Negotiation Impl$2,404,580,000 $2,404,580,000
617023Apportioned in FY 2024 and future fiscal years - Marketplace User Fees (Section 1311&1321, P.L.111-1$926,464,854 $926,464,854
61708Apportioned in FY 2024 and future fiscal years - Medicaid Regulations Study and Report (Section 7001$2,854,052 $2,854,052
61706Apportioned in FY 2024 and future fiscal years - Medicare and Medicaid Extenders Act of 2010 (Sectio$6,860,792 $6,860,792
617020Apportioned in FY 2024 and future fiscal years - Medicare Site-of-Service (CURES 4011, P.L.114-255)$256,414 $256,414
61709Apportioned in FY 2024 and future fiscal years - Nursing Home CMPs (ACA 6111, P.L.111-148)$100,614,921 $100,614,921
617017Apportioned in FY 2024 and future fiscal years - Open Payments CMPs (ACA 6002, P.L.111-148)$653,108 $653,108
617034Apportioned in FY 2024 and future fiscal years - Part B Price Inflation Rebate Implementation (Infla$3,500,000 $3,500,000
617035Apportioned in FY 2024 and future fiscal years - Part D Price Inflation Rebate Implementation (Infla$9,690,000 $9,690,000
617036Apportioned in FY 2024 and future fiscal years - Part D Redesign Implementation (Inflation Reduction$41,400,000 $41,400,000
617014Apportioned in FY 2024 and future fiscal years - Post-Acute Care Common Measurement Tool (IMPACT 2a,$2,534,866 $2,534,866
617018Apportioned in FY 2024 and future fiscal years - Prohibition of Inclusion of SSNs (MACRA 501, P.L.11$11,246,645 $11,246,645
61707Apportioned in FY 2024 and future fiscal years - Provider Enrollment Fees (ACA 6401, P.L.111-148)$21,532,018 $21,532,018
617028Apportioned in FY 2024 and future fiscal years - Quality Incentives Computed Tomography (PAMA 218, P$14,518,320 $14,518,320
617010Apportioned in FY 2024 and future fiscal years - RAC Retention Fees (MACRA 505, P.L.114-10)$28,476,177 $28,476,177
617022Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - MSP (Section 302, P.L.$56,531,258 $56,531,258
617021Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - Part A/B (Section 302,$142,341,765 $142,341,765
617027Apportioned in FY 2024 and future fiscal years - Recovery Audit Contractors - Part D (Section 302, P$500,000 $500,000
617029Apportioned in FY 2024 and future fiscal years - Repeal Medicare Payment Cap Therapy Services (BBA 5$19,250,652 $19,250,652
617016Apportioned in FY 2024 and future fiscal years - Repealing SGR and Improving Medicare Payments (MACR$8,628,281 $8,628,281
617024Apportioned in FY 2024 and future fiscal years - Risk Adjustment User Fees (Section 1343, P.L.111-14$54,853,459 $54,853,459
617037Apportioned in FY 2024 and future fiscal years - Skilled Nursing Facility Value-Based Purchasing (CA$1,455,000 $1,455,000
617019Apportioned in FY 2024 and future fiscal years - Treatment of Cancer Hospitals (CURES 16002, P.L.114$1,968,433 $1,968,433
617011Apportioned in FY 2024 and future fiscal years - Value-Based Purchasing Program for SNFs (PAMA 215,$2,428,409 $2,428,409
6190Total budgetary resources available$7,114,836,702+$350,000
$7,115,186,702
See footnotes below
Footnotes for line 6190 (Previous):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes for line 6190 (Current):

A1: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Footnotes

Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.

NumberText
A1
The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. [Rationale: Footnote signifies that this TAFS has received or may receive an automatic apportionment.]

Notes about this page

  • † Links to public laws are automatically generated and are not guaranteed to be accurate.